Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone

Baisakhi Saha, Pavinder Kaur, Denice Tsao-Wei, Wesley Y. Naritoku, Susan Groshen, Ram Datar, Lawrence W. Jones, S. Ashraf Imam

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND. The concurrent determination of methylation status of E-cadherin gene and E-cadherin protein expression remains scant in metastatic prostate cancer cells in bone, the most prevalent site for metastatic growth. Therefore, the study was undertaken to ascertain the methylation status of E-cadherin gene, a most frequent and known epigenetic mechanism of its regulation, and the protein expression in prostate tissue biopsy specimen. METHODS. The methylation of E-cadherin gene was determined by methylation specific-PCR and the protein expression by immunohistochemical method in the consecutive sections of each prostate tissue biopsy specimen. RESULTS. The unmethylated E-cadherin gene and homogeneous E-cadherin protein expression was significantly associated with BPH as compared to the primary prostate carcinoma (Fisher's Exact P<0.001). A significant association was observed between the concurrent methylated gene and markedly reduced expression of the protein in the primary prostate cancer cells as compared to the BPH cells, suggesting methylation-dependent regulation of the gene expression in these cases. In contrast to the primary cancer, a highly significant increase in the frequency of metastatic prostate cancer cells in bone exhibited the concurrent expression of unmethylated gene and homogeneous protein (Fisher's Exact P<0.001). CONCLUSIONS. The study clearly demonstrated a significant association of the concurrent expression of unmethylated E-cadherin gene and E-cadherin protein with metastatic prostate cancer cells in bone, and that its expression may have a role in the intercellular adhesion in the formation of metastatic lesions in bone.

Original languageEnglish
Pages (from-to)1681-1688
Number of pages8
JournalProstate
Volume68
Issue number15
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Cadherins
Prostatic Neoplasms
Bone and Bones
Methylation
Genes
Proteins
Prostate
Biopsy
Gene Expression Regulation
Epigenomics
Carcinoma
Polymerase Chain Reaction
Growth

Keywords

  • Bone metastasis
  • Immunohistochemistry
  • Methylated E-cadherin gene
  • MS-PCR
  • Prostate cancer

ASJC Scopus subject areas

  • Urology
  • Oncology
  • Medicine(all)

Cite this

Saha, B., Kaur, P., Tsao-Wei, D., Naritoku, W. Y., Groshen, S., Datar, R., ... Imam, S. A. (2008). Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone. Prostate, 68(15), 1681-1688. https://doi.org/10.1002/pros.20836

Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone. / Saha, Baisakhi; Kaur, Pavinder; Tsao-Wei, Denice; Naritoku, Wesley Y.; Groshen, Susan; Datar, Ram; Jones, Lawrence W.; Imam, S. Ashraf.

In: Prostate, Vol. 68, No. 15, 01.11.2008, p. 1681-1688.

Research output: Contribution to journalArticle

Saha, B, Kaur, P, Tsao-Wei, D, Naritoku, WY, Groshen, S, Datar, R, Jones, LW & Imam, SA 2008, 'Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone', Prostate, vol. 68, no. 15, pp. 1681-1688. https://doi.org/10.1002/pros.20836
Saha, Baisakhi ; Kaur, Pavinder ; Tsao-Wei, Denice ; Naritoku, Wesley Y. ; Groshen, Susan ; Datar, Ram ; Jones, Lawrence W. ; Imam, S. Ashraf. / Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone. In: Prostate. 2008 ; Vol. 68, No. 15. pp. 1681-1688.
@article{558ae0edd8424b90ae310fd5fa525cd4,
title = "Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone",
abstract = "BACKGROUND. The concurrent determination of methylation status of E-cadherin gene and E-cadherin protein expression remains scant in metastatic prostate cancer cells in bone, the most prevalent site for metastatic growth. Therefore, the study was undertaken to ascertain the methylation status of E-cadherin gene, a most frequent and known epigenetic mechanism of its regulation, and the protein expression in prostate tissue biopsy specimen. METHODS. The methylation of E-cadherin gene was determined by methylation specific-PCR and the protein expression by immunohistochemical method in the consecutive sections of each prostate tissue biopsy specimen. RESULTS. The unmethylated E-cadherin gene and homogeneous E-cadherin protein expression was significantly associated with BPH as compared to the primary prostate carcinoma (Fisher's Exact P<0.001). A significant association was observed between the concurrent methylated gene and markedly reduced expression of the protein in the primary prostate cancer cells as compared to the BPH cells, suggesting methylation-dependent regulation of the gene expression in these cases. In contrast to the primary cancer, a highly significant increase in the frequency of metastatic prostate cancer cells in bone exhibited the concurrent expression of unmethylated gene and homogeneous protein (Fisher's Exact P<0.001). CONCLUSIONS. The study clearly demonstrated a significant association of the concurrent expression of unmethylated E-cadherin gene and E-cadherin protein with metastatic prostate cancer cells in bone, and that its expression may have a role in the intercellular adhesion in the formation of metastatic lesions in bone.",
keywords = "Bone metastasis, Immunohistochemistry, Methylated E-cadherin gene, MS-PCR, Prostate cancer",
author = "Baisakhi Saha and Pavinder Kaur and Denice Tsao-Wei and Naritoku, {Wesley Y.} and Susan Groshen and Ram Datar and Jones, {Lawrence W.} and Imam, {S. Ashraf}",
year = "2008",
month = "11",
day = "1",
doi = "10.1002/pros.20836",
language = "English",
volume = "68",
pages = "1681--1688",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "15",

}

TY - JOUR

T1 - Unmethylated E-cadherin gene expressionis significantly associated with metastatic human prostate cancer cells in bone

AU - Saha, Baisakhi

AU - Kaur, Pavinder

AU - Tsao-Wei, Denice

AU - Naritoku, Wesley Y.

AU - Groshen, Susan

AU - Datar, Ram

AU - Jones, Lawrence W.

AU - Imam, S. Ashraf

PY - 2008/11/1

Y1 - 2008/11/1

N2 - BACKGROUND. The concurrent determination of methylation status of E-cadherin gene and E-cadherin protein expression remains scant in metastatic prostate cancer cells in bone, the most prevalent site for metastatic growth. Therefore, the study was undertaken to ascertain the methylation status of E-cadherin gene, a most frequent and known epigenetic mechanism of its regulation, and the protein expression in prostate tissue biopsy specimen. METHODS. The methylation of E-cadherin gene was determined by methylation specific-PCR and the protein expression by immunohistochemical method in the consecutive sections of each prostate tissue biopsy specimen. RESULTS. The unmethylated E-cadherin gene and homogeneous E-cadherin protein expression was significantly associated with BPH as compared to the primary prostate carcinoma (Fisher's Exact P<0.001). A significant association was observed between the concurrent methylated gene and markedly reduced expression of the protein in the primary prostate cancer cells as compared to the BPH cells, suggesting methylation-dependent regulation of the gene expression in these cases. In contrast to the primary cancer, a highly significant increase in the frequency of metastatic prostate cancer cells in bone exhibited the concurrent expression of unmethylated gene and homogeneous protein (Fisher's Exact P<0.001). CONCLUSIONS. The study clearly demonstrated a significant association of the concurrent expression of unmethylated E-cadherin gene and E-cadherin protein with metastatic prostate cancer cells in bone, and that its expression may have a role in the intercellular adhesion in the formation of metastatic lesions in bone.

AB - BACKGROUND. The concurrent determination of methylation status of E-cadherin gene and E-cadherin protein expression remains scant in metastatic prostate cancer cells in bone, the most prevalent site for metastatic growth. Therefore, the study was undertaken to ascertain the methylation status of E-cadherin gene, a most frequent and known epigenetic mechanism of its regulation, and the protein expression in prostate tissue biopsy specimen. METHODS. The methylation of E-cadherin gene was determined by methylation specific-PCR and the protein expression by immunohistochemical method in the consecutive sections of each prostate tissue biopsy specimen. RESULTS. The unmethylated E-cadherin gene and homogeneous E-cadherin protein expression was significantly associated with BPH as compared to the primary prostate carcinoma (Fisher's Exact P<0.001). A significant association was observed between the concurrent methylated gene and markedly reduced expression of the protein in the primary prostate cancer cells as compared to the BPH cells, suggesting methylation-dependent regulation of the gene expression in these cases. In contrast to the primary cancer, a highly significant increase in the frequency of metastatic prostate cancer cells in bone exhibited the concurrent expression of unmethylated gene and homogeneous protein (Fisher's Exact P<0.001). CONCLUSIONS. The study clearly demonstrated a significant association of the concurrent expression of unmethylated E-cadherin gene and E-cadherin protein with metastatic prostate cancer cells in bone, and that its expression may have a role in the intercellular adhesion in the formation of metastatic lesions in bone.

KW - Bone metastasis

KW - Immunohistochemistry

KW - Methylated E-cadherin gene

KW - MS-PCR

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=55249111607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249111607&partnerID=8YFLogxK

U2 - 10.1002/pros.20836

DO - 10.1002/pros.20836

M3 - Article

C2 - 18712716

AN - SCOPUS:55249111607

VL - 68

SP - 1681

EP - 1688

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 15

ER -